Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Junior energy stock pops on Pacific Rubiale investment

Sean Mason Sean Mason, Freelance
0 Comments| May 28, 2012

{{labelSign}}  Favorites
{{errorMessage}}

Stockhouse Canadian Small and Micro-cap Stock Report for Monday, May 28, 2012

TORONTO (SHfn) – CGX Energy (TSX: V.OYL, Stock Forum) shares jumped 31% to 42 cents on more than three million shares traded Monday after the oil and gas explorer said it has entered into a definitive subscription agreement in which Pacific Rubiale Energy (TSX: T.PRE, Stock Forum) has subscribed for 85,714,285 units of CGX by way of private placement at a price per unit of 35 cents for an aggregate purchase price of $30 million. Pacific Rubiales will hold approximately 35% of CGX Energy's issued and outstanding common shares on closing of the private placement.

As well, shares of Tigray Resources (TSX: V.TIG, Stock Forum) moved up 15% to 23 cents as the junior explorer reported diamond drill results for eight new holes in the Northern and Central Lenses at the Terakimti volcanogenic massive sulfide copper-gold discovery on its Harvest project in Ethiopia, which included 6.1 metres of 27.2 grams per tonne (g/t) gold, 13.9 metres of 1.9% copper, 18 g/t silver, and 3.6% zinc.

Nuvo Research (TSX: T.NRI , Stock Forum), meanwhile, announced that it has entered into a license and supply agreement granting Paladin Labs (TSX: T.PLB, Stock Forum) exclusive Canadian rights to market and sell Synera, a topical patch that combines lidocaine, tetracaine, and heat. Under the terms of the agreements, Nuvo will receive a double-digit royalty on net sales of Synera in Canada and will supply Synera to Paladin. In addition, Paladin has agreed to loan Nuvo $8.0 million in two equal tranches of $4.0 million each. Nuvo Research stock popped 12% to 10 cents.

Top Canadian Small/Micro-cap Advancers (as of 1:30 PM Eastern)
Top Canadian Small/Micro-cap Decliners

To read more articles by Sean Mason please click here



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company